Form 4 for AVBP ArriVent BioPharma, Inc.
Accepted 2025-07-15 00:00:00 ET · period of report 2025-07-11 · accession 0001104659-25-067928 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-07-15 | 2025-07-11 | AVBP | LaChapelle Robin | COO | M - OptEx | $2.28 | +11.2K | 129.2K | +9% | +$25.4K |
| DM | 2025-07-15 | 2025-07-11 | AVBP | LaChapelle Robin | COO | M - OptEx | $0.00 | -11.2K | 410 | -96% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-11 | M | A | 2,050 | $2.28 | 126,633 | D | — | — | |
| 2 | Common | Common Stock | 2025-07-11 | M | A | 6,503 | $2.28 | 135,736 | D | — | — | |
| 3 | Common | Common Stock | 2025-07-11 | M | A | 2,600 | $2.28 | 129,233 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2025-07-11 | M | D | 2,600 | $0.00 | 12,873 | D | $2.28 · — to 2032-01-31 | 2,600 Common Stock | (F3) The shares underlying this option vested as to 25% on February 1, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. |
| 5 | Derivative | Stock Option (right to buy) | 2025-07-11 | M | D | 6,503 | $0.00 | 6,370 | D | $2.28 · — to 2032-01-31 | 6,503 Common Stock | (F3) The shares underlying this option vested as to 25% on February 1, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. |
| 6 | Derivative | Stock Option (right to buy) | 2025-07-11 | M | D | 2,050 | $0.00 | 410 | D | $2.28 · — to 2031-09-07 | 2,050 Common Stock | (F2) The shares underlying this option vested as to 25% on September 8, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. |